PerpEquities

Equity · Healthcare

Oscar Health, Inc. (OSCR) perpetual futures

OSCR perpetual futures on 3 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade OSCRUSDT.

Oscar Health, Inc. is a US health insurer offering individual, family, small business, and Medicare Advantage plans, plus its +Oscar technology platform and reinsurance solutions.

$25.48+1.1%NYSE closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

venue perp mark · BingX (OSCR-USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

3/3 live markets
Venues
3
Live markets
3/3
24h volume
$391.6K
Open interest
$174.9K
Best liquidity
$10.4K
LBank
Tightest spread
+51.1 bps
LBank
Highest volume
$376K
BingX
Settlement mix
USDT · 3/3
Perp/spot vol.
0.00x
Spot volume $168.2M
OI / float
0.00%
Float $6.5B
Spot performance
1D-5.50%
5D-20.76%
1M-25.78%
6M+9.23%
YTD+72.09%
1Y+49.97%

Venue matrix

3 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeOSCR-USDTTrading$25.45+5.5% APR
+0.00500% every 8h
+55.0 bps$2.1K$376K$2.4KUSDT-
LBankTradeOSCR/USDTTrading$25.480.0% APR
0.000% every 8h
+51.1 bps$10.4K$14.2K$125.6KUSDT50x
OKXTradeOSCR/USDTTrading$25.450.0% APR
0.000% every 8h
+51.1 bps$2.3K$1.4K$46.9KUSDT10x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Thin liquidity · 1 of 3 venues absorb $10k · Typical cost: +130.6 bps

Cheapest execution: LBank · +130.6 bps

Too thin: OKX, BingX

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

OSCR

Tightest spread

OSCR

Highest volume

OSCR

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-11-05 · next report 2027-02-09 · Updated 4h ago
All financials →

Valuation & key figures

Market cap
$7.68B
All share classes · Updated 4h ago
Revenue
$17.5B
Trailing 12 months
Revenue growth
+61%
FY2026 consensus
Profit margin
4.9%
Net income / revenue, TTM
P/E
8.9×
Forward 10.8× (FY2026)
P/S
0.4×
Price / sales, TTM
Peer P/E
37.9×
Similar listed perps
EV / EBITDA
3.9×
TTM
Free cash flow
$4.1B
Trailing 12 months
Net income
$855M
Trailing 12 months
Revenue estimate
$18.9B
FY2026 consensus
Earnings
2027-02-09
Revenue est. $4.46B · Updated 4h ago
Dividend
–
No dividend
Revenue (TTM)$17.5B+54.8% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)5.3%+7.2 pp vs a year agoOperating income $931M
Net income (TTM)$855M+450.5% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$4.1B+456.9% vs a year agoCapex $40.9M
Diluted EPS (TTM)$2.42+326.2% vs a year agoSum of the last 4 quarters
Net cash$7.06B+200.2% vs a year agoCash + short-term investments - debt
  • Last report (2026-11-05): revenue beat by 9.5%, EPS beat by 440.7%Revenue $5.14B vs $4.69B expected (+9.5%); EPS $0.49 vs -$0.14 (+440.7%).
  • Revenue growth accelerating: 72.1% year on yearQ3 '26 revenue $5.14B, against an average of 40.9% over the four quarters before.
  • Operating margin 5.3% (TTM), +7.2 pp on a year agoOperating income grew 542.8% while revenue grew 54.8%.
  • Capex 0.2% of revenue (a year ago 0.3%)$40.9M invested in the last 4 quarters (+19.9% on a year earlier). Free cash flow $4.1B = 478.9% of net income.

Revenue, operating income and growth

quarterly
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 216 lines Oscar Health, Inc. reported to the SEC

Next catalyst

Catalysts

Earnings
2027-02-09
Revenue est. $4.46B · Updated 4h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20262.35$18.9B+61%5
FY 20272.60$21.1B+12%6
FY 20283.02$24.4B+16%6
FY 20294.07$31.7B+30%3
FY 20304.46$32.5B+3%2
Q1 20272.40$5.3B+14%3
Source: FMP · Consensus

Company events

6
2027-02-09EarningsActual - / Estimate -1.08-
2026-11-05Earnings · Before market openActual 0.49 / Estimate -0.144Beat
2026-08-06Earnings · Before market openActual 1.10 / Estimate 0.403Beat
2026-05-06EarningsActual 2.07 / Estimate 1.21Beat
2026-02-10EarningsActual -1.24 / Estimate -0.921Miss
2025-11-06EarningsActual -0.53 / Estimate -0.55Beat

Peer comparison

Similar listed perps

Company data

Company intelligence

Updated: Nov 22, 2026, 09:25 AM UTC

Company profile

Sector
Healthcare
Industry
Medical - Healthcare Plans
Chief executive
Mark Thomas Bertolini
Employees
2,305
IPO date
Mar 3, 2021
Country
US
Exchange
New York Stock Exchange
Website
Altman Z-scorei1.9
Piotroski scorei6/9
Overall ratingiA-
Owner earningsi$2.06B$6.17 per share
ESG risk ratingiB-Industry rank: 13/15

Rating factors

Return on equityi
5/5
Return on assetsi
4/5
Debt to equityi
3/5
Price to earningsi
2/5
Price to booki
2/5
Market cap history
$7.65B-20.4%Aug 2026 – Nov 2026
$7.65B$8.96B$10.28BHigh: $10.28B · 2026-10-12Latest: $7.65B · 2026-11-20Aug 2026Sep 2026Oct 2026Nov 2026
Latest: $7.65B · 2026-11-20High: $10.28B · 2026-10-12Low: $7.65B · 2026-11-20
Largest fund holders
FundWeightShares held
VTI0.01%7.6M
IWM0.26%6.4M
AVUV0.62%5.9M
VB0.09%5.5M
NJM0.12%4.8M
VBK0.21%3.2M
VXF0.08%2.6M
FSSNX0.21%2.3M
IWO0.52%2.3M
NLO0.23%1.7M
FESM0.76%1.5M
FCAGX0.51%1.5M

Analyst track record

How the analysts covering OSCR have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings43105
Analysts1517
Buy / hold / sell12 / 24 / 734 / 41 / 30
Upgrades / downgrades / initiations7 / 0 / 27 / 8 / 8
Price targets hit / missed22 / 19 (54%)73 / 28 (72%)
Avg. return after a rating (TipRanks)+18.6%+51.1%
Best / worst call+137.9% / -46.6%+227.1% / -46.6%

After buy calls on this stock: median 21-day move +0.5% vs S&P 500 -0.4% (n = 36)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Stephen BaxterWells Fargo38% hit rate on this stock · 13 targets measuredHoldtarget $27.00Sep 15, 2026

Latest ratings

DateAnalystCallTarget
Nov 6, 2026Jessica TassanPiper SandlerNov 6, 2026BuyReiterated$45.00↗
Nov 6, 2026Jonathan YongUBSNov 6, 2026HoldMaintained$38.00↗
Nov 6, 2026Andrew Mok CFABarclaysNov 6, 2026BuyMaintained$49.00↗
Oct 12, 2026Jonathan YongUBSOct 12, 2026HoldReiterated$36.00↗
Sep 23, 2026Jessica TassanPiper SandlerSep 23, 2026BuyMaintained$48.00↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$10.00$15.00$20.00$25.00$30.00$35.00Dec 25 · Buy 1 · Hold 3 · Sell 5Dec 25Jan 26 · Buy 1 · Hold 5 · Sell 3Feb 26 · Buy 2 · Hold 4 · Sell 3Feb 26Mar 26 · Buy 2 · Hold 4 · Sell 3Apr 26 · Buy 2 · Hold 5 · Sell 2Apr 26May 26 · Buy 1 · Hold 7 · Sell 2Jun 26 · Buy 2 · Hold 7 · Sell 1Jun 26Jul 26 · Buy 3 · Hold 7 · Sell 1Aug 26 · Buy 2 · Hold 7 · Sell 2Aug 26Sep 26 · Buy 3 · Hold 7 · Sell 3Oct 26 · Buy 3 · Hold 7 · Sell 3Oct 26Nov 26 · Buy 3 · Hold 6 · Sell 2Dec 25 · avg. target $15.04Jan 26 · avg. target $16.29Feb 26 · avg. target $16.00Mar 26 · avg. target $16.00Apr 26 · avg. target $16.44May 26 · avg. target $17.44Jun 26 · avg. target $20.00Jul 26 · avg. target $21.60Aug 26 · avg. target $26.50Sep 26 · avg. target $31.82Oct 26 · avg. target $32.73Nov 26 · avg. target $34.60Dec 25 · month-end close $14.37Jan 26 · month-end close $14.35Feb 26 · month-end close $13.64Mar 26 · month-end close $11.47Apr 26 · month-end close $18.46May 26 · month-end close $22.23Jun 26 · month-end close $28.52Jul 26 · month-end close $31.22Aug 26 · month-end close $29.96Sep 26 · month-end close $30.84Oct 26 · month-end close $30.37Nov 26 · month-end close $24.73

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Nov 20, 2026 · 43 ratings

Frequently asked questions

Where can I trade OSCR perpetual futures?

Oscar Health, Inc. (OSCR) perpetual futures trade on 3 crypto venues, including BingX, LBank, OKX. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade OSCR around the clock?

Yes. Unlike the underlying stock, OSCR perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on OSCR perpetuals?

Right now the OSCR perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to +5.5% across 3 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the OSCR perp price compare to the Oscar Health, Inc. stock?

The venue-median OSCR perp mark is $25.5 versus a reference stock price of $25.5, a basis of -0.1%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a OSCR perpetual future?

A OSCR perpetual is a derivative that tracks the price of Oscar Health, Inc. with no expiry date. It lets you take long or short exposure to Oscar Health, Inc. on crypto venues, around the clock.

What is OSCRUSDT perpetual?

OSCRUSDT is the symbol most crypto exchanges use for the Oscar Health, Inc. perpetual settled in USDT (Tether). It tracks the OSCR share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

OSCR perpetuals · perpequities.comOSCR perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/oscr-perp"><img src="https://perpequities.com/badge/oscr-perp.svg" width="240" height="64" alt="OSCR perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of OSCR perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for OSCR — one email every Sunday.

Watchlist and alerts

Price and funding alerts for OSCR, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X